Eli Lilly reported these results in mid-2025, and the retatrutide availability timeline now points toward potential FDA approval no earlier than 2027, as additional phase 3 trials continue
It became tremendously popular in the United States after Elon Musk proclaimed its benefits
If youre wondering whether youre a good candidate for semaglutide in Naples with Dr Bs practice, see if you can check off the following boxes: Have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher, along with weight-related health issues, such as diabetes, high blood pressure, heart disease, etc
Research shows similar rates of diarrhea whether or not patients were taking metformin alongside their GLP-1 therapy
Potential body composition effects Growth hormone plays established roles in both lipolysis and muscle protein synthesis
Plus, it sounds like targets maybe going even lower - we look for a reduction in 2007